1.99
price down icon4.33%   -0.09
after-market Dopo l'orario di chiusura: 2.00 0.01 +0.50%
loading
Precedente Chiudi:
$2.08
Aprire:
$2.08
Volume 24 ore:
51,156
Relative Volume:
0.26
Capitalizzazione di mercato:
$6.85M
Reddito:
$895.50K
Utile/perdita netta:
$-26.30M
Rapporto P/E:
-1.2134
EPS:
-1.64
Flusso di cassa netto:
$-23.84M
1 W Prestazione:
+8.15%
1M Prestazione:
+39.16%
6M Prestazione:
-55.28%
1 anno Prestazione:
-86.18%
Intervallo 1D:
Value
$1.97
$2.0999
Intervallo di 1 settimana:
Value
$1.85
$2.17
Portata 52W:
Value
$1.3381
$19.00

Mainz Biomed N V Stock (MYNZ) Company Profile

Name
Nome
Mainz Biomed N V
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
26
Name
Cinguettio
Name
Prossima data di guadagno
2025-05-02
Name
Ultimi documenti SEC
Name
MYNZ's Discussions on Twitter

Confronta MYNZ con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
MYNZ
Mainz Biomed N V
1.99 7.59M 895.50K -26.30M -23.84M -1.64
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
475.03 176.18B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
202.81 141.70B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
549.97 43.48B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
200.82 33.02B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.35 33.01B 6.63B 1.17B 1.19B 4.05

Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-14 Iniziato Maxim Group Buy
2024-11-25 Downgrade H.C. Wainwright Buy → Neutral
2023-11-21 Downgrade Cantor Fitzgerald Overweight → Neutral
2022-06-21 Iniziato H.C. Wainwright Buy

Mainz Biomed N V Borsa (MYNZ) Ultime notizie

pulisher
Jul 24, 2025

Does Mainz Biomed N.V. stock pay reliable dividendsFree Stock Market Return Analysis - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Mainz Biomed N.V. stock priceHigh-velocity gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Mainz Biomed, CARE announce collaboration agreement - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany - Nasdaq

Jul 23, 2025
pulisher
Jul 23, 2025

Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Mainz Biomed N.V. stockConsistently profitable trades - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Mainz Biomed N.V. Stock Analysis and ForecastBreakthrough profits - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Why Mainz Biomed N.V. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

ARBI(arbipad) News and UpdatesProtected Capital Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Mainz Biomed N.V. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed reviews accomplishments for first half of 2025 - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed N.V. Announces Key Achievements and Corporate Update for First Half of 2025 - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Mainz Biomed's Dual Breakthrough: FDA Trial Progress and Revolutionary 95% Accurate Pancreatic Cancer Detection - Stock Titan

Jul 15, 2025
pulisher
Jul 12, 2025

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants - 富途牛牛

Jul 12, 2025
pulisher
Jun 25, 2025

Mainz Biomed (MYNZ) Secures State Funding for Pancreatic Cancer Project | MYNZ Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test - FinancialContent

Jun 25, 2025
pulisher
Jun 24, 2025

Mainz Biomed (MYNZ) to Release Quarterly Earnings on Tuesday - Defense World

Jun 24, 2025
pulisher
Jun 21, 2025

Where are the Opportunities in (MYNZ) - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 12, 2025

Mainz Biomed (NASDAQ:MYNZ) Trading Down 1.9% – Here’s What Happened - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

(MYNZ) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 10, 2025

Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Ca - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Study Of Biomarker Panel In Pancreatic Cancer Project - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Cancer Detection | MYNZ Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Phase for Non-Invasive Pancreatic Cancer Screening Test in PancAlert Project - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz initiates feasibility study of biomarker panel in PancAlert project - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project - The Manila Times

Jun 10, 2025

Mainz Biomed N V Azioni (MYNZ) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$298.47
price up icon 0.96%
diagnostics_research DGX
$171.90
price up icon 0.83%
$141.06
price up icon 2.35%
diagnostics_research LH
$267.69
price up icon 6.86%
diagnostics_research MTD
$1,260.75
price up icon 0.28%
diagnostics_research A
$120.35
price up icon 0.74%
Capitalizzazione:     |  Volume (24 ore):